Cobenfy (xanomeline/trospium) - BMS
A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of Xanomeline and Trospium Chloride Capsules (KarXT) in the Treatment of Chinese Adult Participants with Schizophrenia (ChiCTR) - Sep 16, 2026 - P=N/A | N=250 | Not yet recruiting | Sponsor: Peking University Sixth Hospital ( Institute of Mental Health ); Peking University Sixth Hospital ( Institute of Mental Health ) 
New trial • Real-world evidence • CNS Disorders • Psychiatry • Schizophrenia
https://www.chictr.org.cn/showproj.html?proj=339105
 
Sep 16, 2026
 
Prev Next